Table 1. Neurologic symptoms during hospital admissions for babesiosis in patients admitted to Yale-New Haven Hospital, New Haven, Connecticut, USA, January 2011–October 2021*.
Neurologic symptom | No. (%) patients | Peak parasitemia, no. (%) patients |
p value | ||
---|---|---|---|---|---|
<1.0%, n = 45 | 1.0%–10.0%, n = 81 | >10.0%, n = 37 | |||
Headache | 52 (31.9) | 14 (31.1) | 28 (34.6) | 10 (27.0) | 0.711 |
Confusion/delirium | 27 (16.6) | 2 (4.4) | 13 (16.1) | 12 (32.4) | 0.003 |
Impaired consciousness | 24 (14.7) | 4 (8.9) | 9 (11.1) | 11 (29.7) | 0.018 |
Ataxia/gait disorder | 17 (10.4) | 3 (6.7) | 10 (12.4) | 4 (10.8) | 0.632 |
Vision impairment | 10 (6.1) | 5 (11.1) | 4 (4.9) | 1 (2.7) | 0.266 |
Acute syncope | 6 (3.7) | 2 (4.4) | 4 (4.9) | 0 (0.0) | 0.482 |
Language deficit | 5 (3.1) | 0 (0.0) | 5 (6.2) | 0 (0.0) | 0.106 |
Nerve pain | 4 (2.5) | 1 (2.2) | 2 (2.5) | 1 (2.7) | 1.000 |
Focal weakness | 3 (1.8) | 1 (2.2) | 1 (1.2) | 1 (2.7) | 0.794 |
Tremor | 3 (1.8) | 1 (2.2) | 2 (2.5) | 0 (0.0) | 1.000 |
Seizure | 2 (1.3) | 1 (2.2) | 0 (0.0) | 1 (2.7) | 0.252 |
*Total sample (n = 163); Column percentages do not sum to 100% due to many patients being affected by multiple neurologic conditions throughout hospitalization. Boldface type indicates statistical significance.